EXAI - Schrodinger: Solving The Critical Need For AI/ML In The Biopharma Industry
Summary
- SDGR's valuable segment is its software business which represents majority of the revenue.
- There is an increasing demand for AI/ML capabilities by biopharmaceutical companies.
- SDGR's differentiated product stemmed from years of data processing.
For further details see:
Schrodinger: Solving The Critical Need For AI/ML In The Biopharma Industry